In 1981, Hope & Cope was launched under the auspices of the JGH Auxiliary to use specially trained volunteers (many of whom were cancer survivors) to support and counsel cancer patients and their families.
Approximately 3,011 people streamed through the streets of Montreal in August 2005 in the first Weekend to End Breast Cancer, giving a major boost to the treatment and prevention of breast cancer at the Segal Cancer Centre.
Dr. Michael Pollak, Director of the Stroll Cancer Prevention Centre at the JGH, has been chosen to serve as one of two leaders of a new Canada-wide team, aimed at translating fundamental research about breast cancer into effective treatment options for patients.
Dr. Michael Pollak, Director of the Stroll Cancer Prevention Centre at the JGH, has been named to the Royal Society of Canada. The appointment recognizes the wide range of his work as a clinician, researcher and teacher.
In May 2010, Michael Douglas offered public thanks to Dr. Saul Frenkiel, former Chief of the JGH Division of Otolaryngology, for correctly diagnosing the actor’s throat cancer after other physicians had missed it.
Butterflies, Hope & Cope’s uplifting symbol, took to the air by the dozens on July 3, 2007, at the climax of inaugural ceremonies for the JGH Hope & Cope Wellness Centre.
In early 1969, Dr. Richard Margolese wrote an impassioned letter that played a pivotal role in a decision by the hospital’s Board of Directors to ban the sale of cigarettes on its premises.
In 2006, Health and Social Services Minister Philippe Couillard visited the newly completed Segal Cancer Centre to express his admiration for the JGH’s leadership in providing patients with a fully integrated system of cancer treatment and care.
To enable advanced cancer patients to cope with difficulties at the end of life, JGH researchers hope to develop better psychological support through an intervention that helps individuals find meaning in their radically altered lives.
A pioneering research program is connecting artificial intelligence with the new field of radiomics to heighten the effectiveness of cancer treatment by gleaning as much information as possible from radiological imaging technology.